Making a Difference in the Lives of Millions
In vitro diagnostics continue to evolve as the global demand for reliable point-of-care rapid tests for biomarker screening and treatment monitoring rapidly increases. Point-of-care rapid diagnostic tests are designed to address the healthcare professional’s need for fast, efficient, precise and accurate testing without overly complicated, multistep procedures.
Pharmact develops in-vitro diagnostic rapid tests that tackle the greatest medical challenges of modern times by providing high-quality, convenient, and accessible solutions that always exceed the expectations of healthcare professionals and patients.
When the body has been exposed to the SARS-CoV-2 virus, it produces IgM and IgG antibodies in an attempt to defend itself against infection.
By measuring the concentration of those particular antibodies, the BELTEST-IT COV-2 Rapid Test (“Pharmact CoV-2 Rapid Test”) can determine in 20 minutes whether a patient experiencing symptoms has been exposed to the virus within the past 4 to 24 days. It can be used as a point-of-care screening and diagnostic tool.
Fast result in only 20 minutes, easy to operate, highly sensitive, specific and accurate, high throughput with laboratories or healthcare professionals testing a high number of samples in a short time frame.
For professional use only.
The coronavirus has arrived in Germany - and as the number of people who are infected increases, so does the fear of infection. A German company…